Drug profile · INN
trametinib
MEKINIST
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trametinib (MEKINIST) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN trametinib
Brand MEKINIST
Route ORAL
Formulation SOLUTION
ATC code L01EE01
Originator Novartis Pharmaceuticals
Frequently asked questions
What is trametinib?
trametinib (MEKINIST) is an FDA-listed pharmaceutical active ingredient. Associated with Novartis Pharmaceuticals. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for trametinib?
MEKINIST is a marketed brand name for trametinib. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trametinib?
trametinib has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.